Question 1

How many shares of NTLA does CITADEL ADVISORS LLC own?

Accepted Answer

As of 2026-Q2, CITADEL ADVISORS LLC holds 164,712 shares of NTLA (INTELLIA THERAPEUTICS INC).

Question 2

What is CITADEL ADVISORS LLC's NTLA position worth?

Accepted Answer

As of 2026-Q2, CITADEL ADVISORS LLC's NTLA position is worth $2.8M.

Question 3

Is CITADEL ADVISORS LLC buying or selling NTLA?

Accepted Answer

In 2026-Q2, CITADEL ADVISORS LLC decreased their NTLA position (-64.1% change in shares).

Question 4

When did CITADEL ADVISORS LLC first buy NTLA?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in NTLA in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	164,712	-64.1%	$2.8M	0.0%	$16.92	0
2026-Q1	Decreased	458,241	-51.8%	$5.9M	0.0%	$13.60	0
2025-Q4	Increased	950,250	+9076.7%	$8.5M	0.0%	$9.06	44
2025-Q3	Decreased	10,355	-98.5%	$178,831	0.0%	$16.92	0
2025-Q2	Decreased	709,981	-74.3%	$6.7M	0.0%	$9.56	0
2025-Q1	Increased	2.8M	+10.6%	$19.6M	0.0%	$8.07	31
2024-Q4	Increased	2.5M	+152.1%	$29.1M	0.0%	$11.41	46
2024-Q3	Increased	989,439	+29.7%	$20.3M	0.0%	$21.00	36